Prof Eric Allémann
Eric Allémann was born in 1963. He studied pharmacy at the University of Geneva. From 1990 to 1993, he worked on his thesis in the field of parenteral polymeric drug delivery systems with extended release properties. He obtained his Ph.D. in 1993. He went then to the Faculty of Medicine of the University of Sherbrooke (Quebec) for a post-doc. In 1995, he became research associate and lecturer at the University of Geneva. In 1997, the Swiss Confederation for the renewal of academic positions appointed him. He obtained in October 1999 a position of “maître d'enseignement et de recherche”. Since October 2001, he joined the Geneva research center of the pharmaceutical company Bracco Group, as senior research scientist. He was involved in therapeutic and diagnostic nanomedicines. In 2004, he was appointed Manager and was heading the Department of Novel Agents Research at Bracco Research Geneva. In 2009 he became full professor of Pharmaceutical technology at the Geneva-Lausanne School of Pharmacy (EPGL), located at the University of Geneva. Since July 2018, he was elected President of the School of pharmaceutical sciences. Eric Allémann's research interests are focused on the delivery of active substances by means of supramolecular constructs, nano- and microparticles for the controlled release and drug targeting as well as for contrast agents for various medical imaging techniques.
He is (co)-inventor for 15 international patents and has authored and co-authored more than 100 research and review articles.
Additionally to his academic duties, Eric is co-founder of KYLYS a start-up company developing biopolymers